SHELBY MILLER: Open Payments
NPI 1447898408 · GRAND ISLAND, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 21 payments from 17 companies in 2025. Trend: 2023 $505 · 2024 $222 · 2025 $512
Food & beverage: $494Education: $18
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| TerSera Therapeutics LLC | 2 | $52 |
| Pharmacosmos Therapeutics Inc. | 1 | $51 |
| GENZYME CORPORATION | 1 | $43 |
| PFIZER INC. | 2 | $40 |
| Astellas Pharma US Inc | 2 | $34 |
| ABBVIE INC. | 1 | $31 |
| Caris MPI, Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $23 |
Products named: MONOFERRIC, AYVAKIT, IBRANCE, LYNOZYFIC, Zoladex, Vyloy, ELAHERE, MI CANCER SEEK.
Industry payments across NE — which companies pay providers there.
